Skip to main content

Rabbit Recombinant Monoclonal RET phospho Y1096 antibody. Suitable for Dot, WB and reacts with Synthetic peptide - Human, Human samples.

Be the first to review this product! Submit a review

Images

Western blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (AB322346), expandable thumbnail
  • Western blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (AB322346), expandable thumbnail
  • Dot Blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (AB322346), expandable thumbnail

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer

pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA

Form
Liquid
Clonality
Monoclonal

Immunogen

  • The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
DotWBIPFlow CytIHC-P
Human
Expected
Tested
Not recommended
Not recommended
Not recommended
Synthetic peptide - Human
Tested
Not recommended
Not recommended
Not recommended
Not recommended

Tested
Tested

Species
Synthetic peptide - Human
Dilution info
1/1000
Notes

-

Expected
Expected

Species
Human
Dilution info
Use at an assay dependent concentration.
Notes

-

Tested
Tested

Species
Human
Dilution info
1/1000
Notes

-

Not recommended
Not recommended

Species
Synthetic peptide - Human
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Human, Synthetic peptide - Human
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Human, Synthetic peptide - Human
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Human, Synthetic peptide - Human
Dilution info
-
Notes

-

Target data

Function

Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation in response to glia cell line-derived growth family factors (GDNF, NRTN, ARTN, PSPN and GDF15) (PubMed:20064382, PubMed:20616503, PubMed:20702524, PubMed:21357690, PubMed:21454698, PubMed:24560924, PubMed:28846097, PubMed:28846099, PubMed:28953886, PubMed:31118272). In contrast to most receptor tyrosine kinases, RET requires not only its cognate ligands but also coreceptors, for activation (PubMed:21994944, PubMed:23333276, PubMed:28846097, PubMed:28846099, PubMed:28953886). GDNF ligands (GDNF, NRTN, ARTN, PSPN and GDF15) first bind their corresponding GDNFR coreceptors (GFRA1, GFRA2, GFRA3, GFRA4 and GFRAL, respectively), triggering RET autophosphorylation and activation, leading to activation of downstream signaling pathways, including the MAPK- and AKT-signaling pathways (PubMed:21994944, PubMed:23333276, PubMed:24560924, PubMed:25242331, PubMed:28846097, PubMed:28846099, PubMed:28953886). Acts as a dependence receptor via the GDNF-GFRA1 signaling: in the presence of the ligand GDNF in somatotrophs within pituitary, promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF (PubMed:20616503, PubMed:21994944). Required for the molecular mechanisms orchestration during intestine organogenesis via the ARTN-GFRA3 signaling: involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue (By similarity). Mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced cell-signaling in the brainstem which triggers an aversive response, characterized by nausea, vomiting, and/or loss of appetite in response to various stresses (PubMed:28846097, PubMed:28846099, PubMed:28953886). Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner (PubMed:20702524, PubMed:21357690). Also active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage (PubMed:21357690). Triggers the differentiation of rapidly adapting (RA) mechanoreceptors (PubMed:20064382). Involved in the development of the neural crest (By similarity). Regulates nociceptor survival and size (By similarity). Phosphorylates PTK2/FAK1 (PubMed:21454698). Isoform 1. Isoform 1 in complex with GFRAL induces higher activation of MAPK-signaling pathway than isoform 2 in complex with GFRAL.

Alternative names

Rabbit Recombinant Monoclonal RET phospho Y1096 antibody. Suitable for Dot, WB and reacts with Synthetic peptide - Human, Human samples.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Monoclonal
Immunogen
  • The exact immunogen used to generate this antibody is proprietary information.
Clone number
EPR26918-23
Purification technique
Affinity purification Protein A
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes

Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

3 product images

  • Western blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (ab322346), expandable thumbnail

    Western blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (ab322346)

    Blocking and diluting buffer and concentration: 5% NFDM/TBST.

    In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.

    In Western blot, Anti-Ret antibody [EPR2871] (Anti-Ret antibody [EPR2871] ab134100) staining at 1/1000 dilution.

    All lanes: Western blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (ab322346) at 1/1000 dilution

    Lane 1: Untreated TT (human thyroid carcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg

    Lane 2: TT treated with 1mM pervanadate for 30min whole cell lysate (untreated membrane) at 20 µg

    Lane 3: Untreated TT whole cell lysate (Alkaline phosphatase treated membrane) at 20 µg

    Lane 4: TT treated with 1mM pervanadate for 30min whole cell lysate (Alkaline phosphatase treated membrane) at 20 µg

    Secondary

    All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution

    Observed band size: 175 kDa, 36 kDa

    Exposure time: 180s

  • Western blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (ab322346), expandable thumbnail

    Western blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (ab322346)

    Blocking and diluting buffer and concentration: 5% NFDM/TBST.

    The up-regulation of Ret phospho Y1096 is induced by GDNF treatment (PMID: 12091387).

    In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.

    In Western blot, Anti-Ret antibody [EPR2871] (Anti-Ret antibody [EPR2871] ab134100) staining at 1/1000 dilution.

    All lanes: Western blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (ab322346) at 1/1000 dilution

    Lane 1: Untreated TT (human thyroid carcinoma epithelial cell) whole cell lysate at 40 µg

    Lane 2: TT treated with 1mM GDNF for 30 mintues whole cell lysate at 40 µg

    Secondary

    All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution

    Observed band size: 175 kDa, 36 kDa

    Exposure time: 180s

  • Dot Blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (ab322346), expandable thumbnail

    Dot Blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (ab322346)

    Dot blot analysis of Ret (phospho Y1096) using ab322346 at 1:1000 (0.522 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1:10,000 dilution.

    Lane1: Human Ret (phospho Y1096) peptide

    Lane2: Ret non-phospho peptide

    Lane3: Human Ret (phospho Y1090) peptide

    Exposure time: 180 seconds.

    Blocking and diluting buffer and concentration: 5% NFDM/TBST.

    This antibody does cross-activity with Ret (phospho Y1090) at higher concentrations by dot blot.

    All lanes: Dot Blot - Anti-Ret (phospho Y1096) antibody [EPR26918-23] (ab322346) at 1/1000 dilution

    Lane 1: Human Ret (phospho Y1096) peptide

    Lane 2: Ret non-phospho peptide

    Lane 3: Human Ret (phospho Y1090) peptide

    Secondary

    All lanes: Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/10000 dilution

    Exposure time: 180s

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com